GlassScriptPhysician profile
Shieun Hong
NPI 1922467299
$3,870.48
in general payments reported to CMS, 2019-2025
19 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,920 · 2022: $816 · 2023: $569 · 2024: $385 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,015.56 | 2021-2025 | |
| Nestle Healthcare Nutrition INC. | $626.53 | 2021-2023 | |
| Fresenius USA Marketing, INC. | $398.05 | 2021-2025 | Velphoro, Korsuva, Velphoro |
| Lilly USA, LLC | $367.84 | 2021-2024 | Trulicity, Mounjaro, Baqsimi |
| Novo Nordisk INC | $268.26 | 2021 | |
| Novartis Pharmaceuticals Corporation | $202.98 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $156.98 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $145.23 | 2021-2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $145.14 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $101.25 | 2021 | |
| Amarin Pharma, INC. | $93.59 | 2021-2022 | |
| Eisai INC. | $92.61 | 2021 | |
| Amgen INC. | $61.85 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.61 | 2021 | |
| Lundbeck LLC | $46.80 | 2024-2025 | Rexulti |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $27.55 | 2021 | |
| Radius Health, INC. | $24.78 | 2021 | |
| Scpharmaceuticals INC. | $24.03 | 2025 | |
| Vivus LLC | $19.84 | 2023 | Pancreaze |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shieun Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.